bpc 157 transformation BPC-157 An FDA Panel Just Endorsed

Reconstitution techniques

(iii) Adoption of Public Health Reporting Using TEFCA Measure as an Optional Bonus Measure Beginning With the CY 2026 Performance Period/2028 MIPS Payment Year In the CY 2026 PFS proposed rule, we proposed to adopt an optional bonus measure under the Public Health and Clinical Data Exchange objective for health information exchange with a PHA that occurs using TEFCA (the Public Health Reporting Using TEFCA measure) beginning with the CY 2026 performance period/2028 MIPS payment year (90 FR 32730 through 33732)

From a 1.67mg/ml solution, it requires 15 units

For all sites: you are injecting into the subcutaneous fat layer